Health Canada disclosing more information on pending generic drug submissions
Dormant drug status can trigger generic access to an alternate Canadian Reference Product
Pharma in Brief’s 2023 Year in Review and Trends for 2024
Florida approved to import Canadian prescription drugs
New Canadian Drug Agency formed, while National Pharmacare bill is delayed into 2024
Federal Court refuses to issue injunction on infringed antibody formulation patent
What is a natural health product? Health Canada’s findings upheld by Federal Courts
Ontario proposes removing barrier to listing “well-established drugs” on its public formulary
Federal Court: Transferring drug submission does not require re-serving Notice of Allegation
Subscribe: Subscribe via RSS
Blogs
Firm/Org